Global Thromboelastography (TEG) Machine Market Growth 2025-2031

Publication ID:

LPI04251994

Publication Date:

April 18, 2025

Pages:

125

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

Medical Devices [2]

Pharma & Healthcare [3]

Description:

The global Thromboelastography (TEG) Machine market size is predicted to grow from US$ 365 million in 2025 to US$ 789 million in 2031; it is expected to grow at a CAGR of 13.7% from 2025 to 2031.
Thromboelastography (Thromboelastography) is a new blood viscoelastic detection system suitable for bedside detection. It uses whole blood samples to monitor the whole process of blood coagulation and fibrinolysis, which can well make up for the deficiency of traditional blood coagulation detection.
Thromboelastogram provides a general picture of coagulation function. It is an inspection item that can dynamically monitor the whole process of coagulation and fibrinolysis. It can completely describe the whole process of a blood sample from coagulation initiation, coagulation and dissolution, and help doctors quickly judge the patient"s coagulation status (high coagulation, low coagulation and fibrinolytic hyperactivity) and analyze the causes.
It is of great value in clinical evaluation of coagulation function, guidance of component transfusion, prediction of thrombosis/bleeding risk and guidance of medication.
Haemonetics, Werfenlife, Framar Hemologix SRL, Lepco Diagnostics, Sienco and so on are the main manufacturers of thromboelastography.The top five global manufacturers account for 77% of total sales.North America and Europe are the main production regions of thromboelastographs.North America accounts for 42% of the global production of thromboelastographs, ranking first in the world.Europe was next with 34 percent.North America is the world"s largest consumer region of thromboelastograms, accounting for 39% of global sales.Europe was second with 21 percent.
The 鈥淭hromboelastography (TEG) Machine Industry Forecast鈥� looks at past sales and reviews total world Thromboelastography (TEG) Machine sales in 2024, providing a comprehensive analysis by region and market sector of projected Thromboelastography (TEG) Machine sales for 2025 through 2031. With Thromboelastography (TEG) Machine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Thromboelastography (TEG) Machine industry.
This Insight Report provides a comprehensive analysis of the global Thromboelastography (TEG) Machine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Thromboelastography (TEG) Machine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global Thromboelastography (TEG) Machine market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Thromboelastography (TEG) Machine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Thromboelastography (TEG) Machine.
This report presents a comprehensive overview, market shares, and growth opportunities of Thromboelastography (TEG) Machine market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Single and Double Channel
Four Channels
Others
Segmentation by Application:
Hospitals
Maternal and Child Health Service
Laboratory
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Haemonetics
Lepu Technology
Biomart
Medcaptain
Ud-bio
Chongqing Nanfang
WITEYE
Render
Guizhou Jinjiu Biotech
Chongqing Dingrun
Zhejiang Shengyu
Bio-zircon
WerfenLife
Framar Hemologix srl
Sienco
Key Questions Addressed in this Report
What is the 10-year outlook for the global Thromboelastography (TEG) Machine market?
What factors are driving Thromboelastography (TEG) Machine market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Thromboelastography (TEG) Machine market opportunities vary by end market size?
How does Thromboelastography (TEG) Machine break out by Type, by Application?

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Thromboelastography (TEG) Machine Annual Sales 2020-2031
2.1.2 World Current & Future Analysis for Thromboelastography (TEG) Machine by Geographic Region, 2020, 2024 & 2031
2.1.3 World Current & Future Analysis for Thromboelastography (TEG) Machine by Country/Region, 2020, 2024 & 2031
2.2 Thromboelastography (TEG) Machine Segment by Type
2.2.1 Single and Double Channel
2.2.2 Four Channels
2.2.3 Others
2.3 Thromboelastography (TEG) Machine Sales by Type
2.3.1 Global Thromboelastography (TEG) Machine Sales Market Share by Type (2020-2025)
2.3.2 Global Thromboelastography (TEG) Machine Revenue and Market Share by Type (2020-2025)
2.3.3 Global Thromboelastography (TEG) Machine Sale Price by Type (2020-2025)
2.4 Thromboelastography (TEG) Machine Segment by Application
2.4.1 Hospitals
2.4.2 Maternal and Child Health Service
2.4.3 Laboratory
2.4.4 Others
2.5 Thromboelastography (TEG) Machine Sales by Application
2.5.1 Global Thromboelastography (TEG) Machine Sale Market Share by Application (2020-2025)
2.5.2 Global Thromboelastography (TEG) Machine Revenue and Market Share by Application (2020-2025)
2.5.3 Global Thromboelastography (TEG) Machine Sale Price by Application (2020-2025)
3 Global by Company
3.1 Global Thromboelastography (TEG) Machine Breakdown Data by Company
3.1.1 Global Thromboelastography (TEG) Machine Annual Sales by Company (2020-2025)
3.1.2 Global Thromboelastography (TEG) Machine Sales Market Share by Company (2020-2025)
3.2 Global Thromboelastography (TEG) Machine Annual Revenue by Company (2020-2025)
3.2.1 Global Thromboelastography (TEG) Machine Revenue by Company (2020-2025)
3.2.2 Global Thromboelastography (TEG) Machine Revenue Market Share by Company (2020-2025)
3.3 Global Thromboelastography (TEG) Machine Sale Price by Company
3.4 Key Manufacturers Thromboelastography (TEG) Machine Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Thromboelastography (TEG) Machine Product Location Distribution
3.4.2 Players Thromboelastography (TEG) Machine Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 World Historic Review for Thromboelastography (TEG) Machine by Geographic Region
4.1 World Historic Thromboelastography (TEG) Machine Market Size by Geographic Region (2020-2025)
4.1.1 Global Thromboelastography (TEG) Machine Annual Sales by Geographic Region (2020-2025)
4.1.2 Global Thromboelastography (TEG) Machine Annual Revenue by Geographic Region (2020-2025)
4.2 World Historic Thromboelastography (TEG) Machine Market Size by Country/Region (2020-2025)
4.2.1 Global Thromboelastography (TEG) Machine Annual Sales by Country/Region (2020-2025)
4.2.2 Global Thromboelastography (TEG) Machine Annual Revenue by Country/Region (2020-2025)
4.3 Americas Thromboelastography (TEG) Machine Sales Growth
4.4 APAC Thromboelastography (TEG) Machine Sales Growth
4.5 Europe Thromboelastography (TEG) Machine Sales Growth
4.6 Middle East & Africa Thromboelastography (TEG) Machine Sales Growth
5 Americas
5.1 Americas Thromboelastography (TEG) Machine Sales by Country
5.1.1 Americas Thromboelastography (TEG) Machine Sales by Country (2020-2025)
5.1.2 Americas Thromboelastography (TEG) Machine Revenue by Country (2020-2025)
5.2 Americas Thromboelastography (TEG) Machine Sales by Type (2020-2025)
5.3 Americas Thromboelastography (TEG) Machine Sales by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Thromboelastography (TEG) Machine Sales by Region
6.1.1 APAC Thromboelastography (TEG) Machine Sales by Region (2020-2025)
6.1.2 APAC Thromboelastography (TEG) Machine Revenue by Region (2020-2025)
6.2 APAC Thromboelastography (TEG) Machine Sales by Type (2020-2025)
6.3 APAC Thromboelastography (TEG) Machine Sales by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Thromboelastography (TEG) Machine by Country
7.1.1 Europe Thromboelastography (TEG) Machine Sales by Country (2020-2025)
7.1.2 Europe Thromboelastography (TEG) Machine Revenue by Country (2020-2025)
7.2 Europe Thromboelastography (TEG) Machine Sales by Type (2020-2025)
7.3 Europe Thromboelastography (TEG) Machine Sales by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Thromboelastography (TEG) Machine by Country
8.1.1 Middle East & Africa Thromboelastography (TEG) Machine Sales by Country (2020-2025)
8.1.2 Middle East & Africa Thromboelastography (TEG) Machine Revenue by Country (2020-2025)
8.2 Middle East & Africa Thromboelastography (TEG) Machine Sales by Type (2020-2025)
8.3 Middle East & Africa Thromboelastography (TEG) Machine Sales by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Thromboelastography (TEG) Machine
10.3 Manufacturing Process Analysis of Thromboelastography (TEG) Machine
10.4 Industry Chain Structure of Thromboelastography (TEG) Machine
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Thromboelastography (TEG) Machine Distributors
11.3 Thromboelastography (TEG) Machine Customer
12 World Forecast Review for Thromboelastography (TEG) Machine by Geographic Region
12.1 Global Thromboelastography (TEG) Machine Market Size Forecast by Region
12.1.1 Global Thromboelastography (TEG) Machine Forecast by Region (2026-2031)
12.1.2 Global Thromboelastography (TEG) Machine Annual Revenue Forecast by Region (2026-2031)
12.2 Americas Forecast by Country (2026-2031)
12.3 APAC Forecast by Region (2026-2031)
12.4 Europe Forecast by Country (2026-2031)
12.5 Middle East & Africa Forecast by Country (2026-2031)
12.6 Global Thromboelastography (TEG) Machine Forecast by Type (2026-2031)
12.7 Global Thromboelastography (TEG) Machine Forecast by Application (2026-2031)
13 Key Players Analysis
13.1 Haemonetics
13.1.1 Haemonetics Company Information
13.1.2 Haemonetics Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.1.3 Haemonetics Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.1.4 Haemonetics Main Business Overview
13.1.5 Haemonetics Latest Developments
13.2 Lepu Technology
13.2.1 Lepu Technology Company Information
13.2.2 Lepu Technology Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.2.3 Lepu Technology Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.2.4 Lepu Technology Main Business Overview
13.2.5 Lepu Technology Latest Developments
13.3 Biomart
13.3.1 Biomart Company Information
13.3.2 Biomart Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.3.3 Biomart Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.3.4 Biomart Main Business Overview
13.3.5 Biomart Latest Developments
13.4 Medcaptain
13.4.1 Medcaptain Company Information
13.4.2 Medcaptain Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.4.3 Medcaptain Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.4.4 Medcaptain Main Business Overview
13.4.5 Medcaptain Latest Developments
13.5 Ud-bio
13.5.1 Ud-bio Company Information
13.5.2 Ud-bio Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.5.3 Ud-bio Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.5.4 Ud-bio Main Business Overview
13.5.5 Ud-bio Latest Developments
13.6 Chongqing Nanfang
13.6.1 Chongqing Nanfang Company Information
13.6.2 Chongqing Nanfang Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.6.3 Chongqing Nanfang Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.6.4 Chongqing Nanfang Main Business Overview
13.6.5 Chongqing Nanfang Latest Developments
13.7 WITEYE
13.7.1 WITEYE Company Information
13.7.2 WITEYE Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.7.3 WITEYE Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.7.4 WITEYE Main Business Overview
13.7.5 WITEYE Latest Developments
13.8 Render
13.8.1 Render Company Information
13.8.2 Render Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.8.3 Render Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.8.4 Render Main Business Overview
13.8.5 Render Latest Developments
13.9 Guizhou Jinjiu Biotech
13.9.1 Guizhou Jinjiu Biotech Company Information
13.9.2 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.9.3 Guizhou Jinjiu Biotech Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.9.4 Guizhou Jinjiu Biotech Main Business Overview
13.9.5 Guizhou Jinjiu Biotech Latest Developments
13.10 Chongqing Dingrun
13.10.1 Chongqing Dingrun Company Information
13.10.2 Chongqing Dingrun Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.10.3 Chongqing Dingrun Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.10.4 Chongqing Dingrun Main Business Overview
13.10.5 Chongqing Dingrun Latest Developments
13.11 Zhejiang Shengyu
13.11.1 Zhejiang Shengyu Company Information
13.11.2 Zhejiang Shengyu Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.11.3 Zhejiang Shengyu Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.11.4 Zhejiang Shengyu Main Business Overview
13.11.5 Zhejiang Shengyu Latest Developments
13.12 Bio-zircon
13.12.1 Bio-zircon Company Information
13.12.2 Bio-zircon Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.12.3 Bio-zircon Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.12.4 Bio-zircon Main Business Overview
13.12.5 Bio-zircon Latest Developments
13.13 WerfenLife
13.13.1 WerfenLife Company Information
13.13.2 WerfenLife Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.13.3 WerfenLife Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.13.4 WerfenLife Main Business Overview
13.13.5 WerfenLife Latest Developments
13.14 Framar Hemologix srl
13.14.1 Framar Hemologix srl Company Information
13.14.2 Framar Hemologix srl Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.14.3 Framar Hemologix srl Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.14.4 Framar Hemologix srl Main Business Overview
13.14.5 Framar Hemologix srl Latest Developments
13.15 Sienco
13.15.1 Sienco Company Information
13.15.2 Sienco Thromboelastography (TEG) Machine Product Portfolios and Specifications
13.15.3 Sienco Thromboelastography (TEG) Machine Sales, Revenue, Price and Gross Margin (2020-2025)
13.15.4 Sienco Main Business Overview
13.15.5 Sienco Latest Developments
14 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.

91制片厂